Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acellbia + Methotrexate in Active Rheumatoid Arthritis
NCT02744196Phase 3Completed
- Sponsor
- BIOCAD
- Start
- Jan 2015
- Primary completion
- Feb 2017
- Modality
- Monoclonal Antibodies
01
Overview
A Phase 3 trial of rituximab in rheumatoid arthritis (RA), sponsored by BIOCAD. Started Jan 2015; status: completed.
02
Drugs
rituximab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT02744196.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02744196.